{"log_id": 3218211776755640854, "direction": 0, "words_result_num": 33, "words_result": [{"probability": {"variance": 0, "average": 1, "min": 1}, "location": {"width": 54, "top": 152, "height": 20, "left": 766}, "words": " zr-hk"}, {"probability": {"variance": 1.1e-05, "average": 0.99798, "min": 0.986923}, "location": {"width": 456, "top": 231, "height": 55, "left": 208}, "words": "儿童病人的不良事件情况与成人已经发现的相似"}, {"probability": {"variance": 0.001635, "average": 0.988738, "min": 0.748323}, "location": {"width": 844, "top": 254, "height": 73, "left": 209}, "words": "不推荐在肾小球滤过率<30mL/min/1.73m2的儿童,肝脏受损的儿童中使用本品。由于没"}, {"probability": {"variance": 0.000521, "average": 0.993235, "min": 0.894106}, "location": {"width": 435, "top": 318, "height": 55, "left": 167}, "words": "有在新生儿中使用的数据,也不推荐使用本品"}, {"probability": {"variance": 0.001072, "average": 0.984032, "min": 0.910829}, "location": {"width": 104, "top": 380, "height": 33, "left": 171}, "words": "[老年用药]"}, {"probability": {"variance": 1e-06, "average": 0.999348, "min": 0.996883}, "location": {"width": 480, "top": 397, "height": 56, "left": 219}, "words": "在临床研究中本品的有效性和安全性没有年龄差异"}, {"probability": {"variance": 6e-06, "average": 0.99636, "min": 0.993943}, "location": {"width": 45, "top": 468, "height": 25, "left": 176}, "words": "种族"}, {"probability": {"variance": 0.000225, "average": 0.996301, "min": 0.904694}, "location": {"width": 845, "top": 463, "height": 72, "left": 217}, "words": "基于LIFE研究,尽管两个治疗组均有效降低黑人患者的血压,但与阿替洛尔相比,氯沙"}, {"probability": {"variance": 3.7e-05, "average": 0.998013, "min": 0.962543}, "location": {"width": 888, "top": 504, "height": 74, "left": 176}, "words": "坦在降低心血管患病率和死亡率方面的益处不适用于黑人高血压伴左心室肥厚患者。在所有参"}, {"probability": {"variance": 0.002472, "average": 0.98832, "min": 0.668329}, "location": {"width": 887, "top": 544, "height": 75, "left": 179}, "words": "加LIPE研究的患者(n=9193)中,与阿替洛尔组相比,氯沙坦组心血管死亡、中风和心肌梗"}, {"probability": {"variance": 0.000158, "average": 0.993599, "min": 0.938493}, "location": {"width": 888, "top": 586, "height": 73, "left": 180}, "words": "死的首要综合终点危险性下降13%(p=0.021)。在LIFE研究中,与阿替洛尔相比,氯沙坦降"}, {"probability": {"variance": 0.001237, "average": 0.988473, "min": 0.817242}, "location": {"width": 887, "top": 627, "height": 74, "left": 182}, "words": "低黑人以外的高血压伴左心室肥厚患者(n=8660)心血管患病和死亡的危险性,观测指标为心血"}, {"probability": {"variance": 0.000458, "average": 0.993075, "min": 0.889987}, "location": {"width": 886, "top": 670, "height": 71, "left": 184}, "words": "管死亡、中风和心肌梗死的首要临床终点综合发生率。(p=0.003).然而,在这个研究中,阿"}, {"probability": {"variance": 0.000118, "average": 0.996283, "min": 0.927058}, "location": {"width": 888, "top": 710, "height": 74, "left": 186}, "words": "替洛尔组的黑人患者与氯沙坦组相比较,其经历首要综合终点的危险性较低(p=0.03)。在黑"}, {"probability": {"variance": 0.005449, "average": 0.977541, "min": 0.640889}, "location": {"width": 886, "top": 751, "height": 74, "left": 189}, "words": "人患者的亚组中(n=533;LIFE研究中6%的患者),阿替洛尔组的263位患者中有29位"}, {"probability": {"variance": 0.00692, "average": 0.971087, "min": 0.5714}, "location": {"width": 865, "top": 794, "height": 71, "left": 204}, "words": "(11%,25.9/每1000患者一年)出现首要终点,而氯沙坦组的270位患者中有46位(17%"}, {"probability": {"variance": 0.019961, "average": 0.936743, "min": 0.48131}, "location": {"width": 220, "top": 866, "height": 41, "left": 193}, "words": "4.8/每1000患者-年"}, {"probability": {"variance": 4e-06, "average": 0.99718, "min": 0.992712}, "location": {"width": 158, "top": 953, "height": 36, "left": 195}, "words": "[药物相互作用]"}, {"probability": {"variance": 7e-06, "average": 0.998177, "min": 0.988344}, "location": {"width": 844, "top": 958, "height": 69, "left": 239}, "words": "在临床药动学的研究中,已确认和氢氯噻嗪、地高辛、华法林、西米替丁、苯巴比妥、酮"}, {"probability": {"variance": 5.7e-05, "average": 0.997047, "min": 0.957711}, "location": {"width": 885, "top": 999, "height": 73, "left": 198}, "words": "康唑和红霉素不具有临床意义上的药物相互作用。已有报道利福平和氟康唑可降低活性代谢产"}, {"probability": {"variance": 2.2e-05, "average": 0.998355, "min": 0.977021}, "location": {"width": 478, "top": 1059, "height": 53, "left": 201}, "words": "物水平。这些相互作用的临床结果还没有得到评价"}, {"probability": {"variance": 0.00021, "average": 0.994499, "min": 0.919045}, "location": {"width": 844, "top": 1082, "height": 69, "left": 246}, "words": "与其他抑制血管紧张素II及其作用的药物一样,本品与保钾利尿药(如:螺内酯,氨苯蝶"}, {"probability": {"variance": 4.4e-05, "average": 0.996209, "min": 0.975025}, "location": {"width": 660, "top": 1133, "height": 62, "left": 204}, "words": "啶,阿米洛利)、补钾剂、或含钾的盐代用品合用时,可导致血钾升高"}, {"probability": {"variance": 0.00015, "average": 0.997006, "min": 0.923076}, "location": {"width": 844, "top": 1164, "height": 69, "left": 249}, "words": "与其他影响钠排泄的药物一样,锂的排泄可能会减少。因此如果锂盐和血管紧张素II受"}, {"probability": {"variance": 5e-06, "average": 0.998382, "min": 0.990554}, "location": {"width": 393, "top": 1228, "height": 50, "left": 207}, "words": "体拮抗剂合用,应仔细监测血清锂盐水平"}, {"probability": {"variance": 0.00614, "average": 0.968458, "min": 0.578524}, "location": {"width": 848, "top": 1248, "height": 68, "left": 252}, "words": "非甾体抗炎药物( NSAIDS)包括选择性环氧合酶-2抑制剂(COX-2抑制剂)可能隆低利"}, {"probability": {"variance": 0.005631, "average": 0.983593, "min": 0.521799}, "location": {"width": 891, "top": 1287, "height": 79, "left": 209}, "words": "尿剂和其他抗高血压药的作用。因此,血管紧张素II受体拮抗剂的抗高血压作用可能会被"}, {"probability": {"variance": 0.005032, "average": 0.95703, "min": 0.783968}, "location": {"width": 286, "top": 1358, "height": 44, "left": 218}, "words": " SAIDS包括COX-2抑制剂削弱"}, {"probability": {"variance": 0.000645, "average": 0.994739, "min": 0.838507}, "location": {"width": 847, "top": 1372, "height": 68, "left": 256}, "words": "对一些正在服用非甾体抗炎药物包括选择性环氧合酶-2抑制剂治疗的有肾功能损害的病"}, {"probability": {"variance": 0.004143, "average": 0.977569, "min": 0.724182}, "location": {"width": 896, "top": 1419, "height": 70, "left": 213}, "words": "人,同时服用血管紧张素II受体拮抗剂可能导致进一步的肾功能损害。这些作用通常表"}, {"probability": {"variance": 0, "average": 0.999166, "min": 0.999166}, "location": {"width": 24, "top": 1499, "height": 24, "left": 219}, "words": "的"}, {"probability": {"variance": 0.000217, "average": 0.989963, "min": 0.961492}, "location": {"width": 161, "top": 1492, "height": 40, "left": 967}, "words": "杭州默沙东"}, {"probability": {"variance": 0, "average": 0.99945, "min": 0.998898}, "location": {"width": 90, "top": 1537, "height": 43, "left": 1051}, "words": "有限公司"}], "language": 3}